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Abstract It is generally accepted that the oxidation of
pentadiene structures of polyunsaturated lipids by lipoxygenase
(LOX) is regio- and enantio-specific, while the free radical-
mediated lipid peroxidation gives stereo-random racemic prod-
ucts. It was confirmed that the oxidation of human low density
lipoprotein (LDL) by 15-LOX from rabbit reticulocytes gave
phosphatidylcholine (PC) and cholesteryl ester (CE) hydroper-
oxides regio-, stereo- and enantio-specifically. 15-LOX also
oxidized human plasma to give specific PC and CE hydroper-
oxides in spite of the presence of high concentrations of
antioxidants. More CE hydroperoxides were formed than PC
hydroperoxides from LDL, but the reverse order was observed
for plasma oxidation. The S/R ratio of the hydroperoxides
decreased during long time incubation but remained significantly
larger than one, while free radical-mediated oxidation of LDL
and plasma gave racemic products.
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1. Introduction
Oxidative modi¢cation of low density lipoprotein (LDL)
and its subsequent uptake by macrophages via receptor path-
ways are thought to play an important role in foam cell for-
mation during early stages of atherosclerosis [1]. However, the
nature and sources of oxidative stress responsible for LDL
oxidation in vivo have not been elucidated. Several oxidizing
enzymes including 15-LOX and myeloperoxidase have been
suggested as being involved [2^4]. Evidence for a putative
role of 15-LOX includes: (i) 15-LOX are capable of oxidizing
human LDL in vitro ([5] and references cited therein), (ii) 15-
LOX are expressed in human and rabbit atherosclerotic le-
sions but not in the normal vessel wall [6,7], (iii) somatic
gene transfer of the 15-LOX to the arterial wall induced the
appearance of oxidized LDL epitopes [8], (iv) LOX inhibitors
are capable of preventing oxidative modi¢cation of LDL [9^
11], and (v) a recently developed LOX inhibitor, which ap-
pears to be speci¢c for mammalian 15-LOX, prevented the
development of atherosclerosis in cholesterol fed rabbits
[12]. The lipid hydroperoxides formed by LOX have been
also proposed to act as source of free radical-mediated sec-
ondary reactions [13,14].
LOX are non-haem iron-containing dioxygenases which
oxygenate polyenic fatty acids containing a 1Z,4Z-pentadiene
system to their 1-hydroperoxyl-2(E),4(Z)-pentadiene product.
In contrast to the non-enzymatic, free radical-mediated lipid
peroxidation, the LOX reaction is regio- and enantio-speci¢c
with respect to the initial hydrogen abstraction and subse-
quent oxygen insertion [15^17]. Originally, it was believed
that LOX can oxidize only free polyenic fatty acid [18]. How-
ever, other studies indicated that certain plant and mamma-
lian LOX are capable of speci¢cally oxidizing phospholipids
and cholesterol esters in biomembranes and lipoproteins
[5,19^23]. Thus, a stereo-speci¢c pattern of oxidation products
in cells and tissues may be regarded as indicator for an in vivo
action of a LOX [24]. The detection of stereo-speci¢c oxidized
polyenic fatty acids in atherosclerotic lesions suggested that
15-LOX may in fact contribute to lipid peroxidation during
early stages of atherogenesis [3,4,25].
On the other hand, it was reported that the oxidation of
LDL by recombinant human 15-LOX proceeds via a non-
enzymatic K-tocopherol-mediated mechanism to give non-spe-
ci¢c lipid hydroperoxides [26^28]. Upston et al. concluded
that K-tocopherol acted as a prooxidant rather than an anti-
oxidant and they found that LDL oxidation was dependent
on the presence of K-tocopherol and that ascorbate, an e⁄-
cient reducing agent of K-tocopheroxyl radical, completely
prevented LDL oxidation [26].
Considering these inconsistent observations, the present
study was carried out to re-examine and con¢rm the regio-,
stereo- and enantio- speci¢city in the oxidation of LDL in-
duced by mammalian 15-LOX, because such speci¢city is the
best criterion to distinguish enzymatic and free radical-medi-
ated oxidation. Phosphatidylcholine hydroperoxides which re-
ceived less attention than cholesteryl ester hydroperoxides
were also analyzed. Furthermore, as an extension, the oxida-
tion of plasma by 15-LOX was also studied and the products
were carefully analyzed.
2. Materials and methods
2.1. Materials
The mammalian 15-LOX was puri¢ed from reticulocytes of rabbits
with bleeding-induced anemia as reported previously [22]. LDL was
isolated from human plasma of healthy donors by ultracentrifugation
as described previously [29] within a density cut-o¡ of 1.019 to 1.063
g/ml and then dialyzed with cellulose membrane in phosphate bu¡ered
saline (PBS, pH 7.4) containing 0.1 mM EDTA. Blood samples from
healthy volunteers were centrifuged at 1000Ug for 5 min to obtain
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plasma, which was used immediately for oxidation. 2,2P-Azobis(4-me-
thoxy-2,4-dimethylvaleronitrile) (MeO-AMVN), used as a lipophilic
radical initiator [30], was obtained from Wako Pure Chemical Ind.
(Osaka, Japan) and used as received.
2.2. Assay systems
Whole human plasma and LDL were oxidized and analyzed in a
similar way. The oxidation was initiated by the addition of LOX or
MeO-AMVN to the reaction medium. The rate of oxidation was
measured from the rates of oxygen uptake and formation of lipid
hydroperoxides with an oxygen electrode (Model YSI 5300, Yellow
Springs Instrument Co., OH, USA) and HPLC respectively.
The enzyme activity of rabbit reticulocyte 15-LOX used in this
study was measured from the rate of oxygen uptake and hydroper-
oxide formation at the initial stage of the oxidation of linoleic acid in
aqueous solution. During this phase of oxidation, the amounts of
oxygen uptake and hydroperoxide formation agreed well.
2.3. Analytical procedures
After the incubation period, the lipids were extracted with chloro-
form/methanol (2:1 by vol) and analyzed for the oxidation products
from PC and CE with an HPLC. CE hydroperoxide (CEOOH) and
CE hydroxide (CEOH) were analyzed as described before [30]. For
analysis of PC hydroperoxide (PCOOH) and PC hydroxide (PCOH)
in some experiments, an ODS column (TSK ODS-80Ts, Tosoh Co.,
Tokyo, Japan; 25 cmU4.6 mm; 5 Wm particle size) was used. The
eluent was acetonitrile/methanol/water (75:21:4 by vol) containing 10
mM choline chloride at a £ow rate of 1.5 ml/min. The column temper-
ature was maintained at 40‡C. For analysis of the regio- and stereo-
isomers of the hydroperoxides, the oxidized lipids were fractionally
collected by HPLC and subsequently treated with sodium borohy-
dride and then transmethylated with TMAH to obtain methyl ester
of hydroxy fatty acids. Aliquots of the transmethylated mixture were
injected to chiral phase HPLC on a Chiralcel OD column (Daicel
Chemical Ind., Tokyo, Japan; 25 cmU4.6 mm; 5 Wm particle size)
with a solvent system of hexane/2-propanol/acetic acid (100:5:0.1 by
vol) and a £ow rate of 1 ml/min. K-Tocopherol was analyzed by
reverse phase HPLC with an electrochemical detector on a LC-18
column (Supelco, Tokyo, Japan) using methanol/tert-butyl alcohol
(9:1) containing 50 mM NaClO4 as an eluent at a £ow rate of 1.0
ml/min.
The oxidation of LDL and plasma was repeated more than ¢ve
times and substantially the same results were obtained for speci¢city
and relative oxidizabilities of PC and CE. A typical example is shown
in the ¢gures.
3. Results
3.1. Oxidation of LDL by 15-lipoxygenase
Firstly, human LDL was oxidized with rabbit reticulocyte
15-LOX in aqueous suspensions and the oxidation products
were carefully analyzed in order to ascertain the speci¢city of
the oxidation process. As observed previously [5], both PC
and CE hydroperoxides were formed, the latter being in high-
er yield than the former. They were fractionally collected with
an HPLC and converted to methyl esters of hydroxy fatty
acids by reduction with sodium borohydride followed by
transmethylation with TMAH. As shown in Fig. 1, 13-hy-
droxy-9Z,11E-octadecadienoate(13-9Z,11E-HODE) was the
major product and the other three isomers 13-9E,11E-
HODE, 9-10E,12Z-HODE and 9-10E,12E-HODE, were
much smaller from both PC and CE hydroperoxides. Further-
more, this 13-9Z,11E-HODE derived from PC and CE hydro-
peroxides was fractionally collected and analyzed with a chiral
phase HPLC. It was found that they were exclusively S form
(Fig. 2). These results demonstrate that the peroxidation of
CE as well as PC of LDL by 15-LOX proceeds enzymatically,
not via a free radical-mediated mechanism.
3.2. Oxidation of human plasma by 15-lipoxygenase and
MeO-AMVN
Human plasma was then used as a substrate and incubated
with rabbit reticulocyte 15-LOX. Upon addition of 15-LOX
to human plasma, a rapid oxygen uptake was observed for
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Fig. 1. Regio- and stereo-speci¢city in the oxidation of LDL in-
duced by 15-LOX. Human LDL (0.75 mg protein/ml) was incubated
with rabbit reticulocyte 15-LOX (10.5 nkat/ml) for 20 min at room
temperature in air, and phosphatidylcholine and cholesteryl ester hy-
droperoxides (PCOOH and CEOOH respectively) were collected us-
ing HPLC and converted to methyl hydroxylinoleate (HODE) as de-
scribed in Section 2.
Fig. 2. Enantio-speci¢city in the oxidation of LDL induced by 15-
lipoxygenase. The reaction conditions are the same as in Fig. 1. 13-
9Z,11E-HODE was collected and analyzed with a chiral phase
HPLC as described in Section 2. The standard PC and CE hydro-
peroxides were prepared by the oxidation of methyl linoleate with a
radical initiator.
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only 5 min and then oxygen was consumed at a much slower
but constant and steady rate (data not shown). In agreement
with the oxygen uptake, PC and CE hydroperoxides were
formed signi¢cantly at the earliest stage in spite of the pres-
ence of many antioxidants and then their formation was
markedly decreased (Fig. 3). The formation of free linoleic
acid hydroperoxide was quite small. In contrast to the oxida-
tion of LDL, more PC hydroperoxide was formed than CE
hydroperoxide. Both PC and CE hydroxides increased with
time. Ubiquinol was oxidized rapidly to ubiquinone but nei-
ther ascorbate nor K-tocopherol was consumed appreciably
even after 300 min incubation (data not shown). To clarify
the mechanism, the geometric and optical isomers of the lino-
leate hydroperoxides were examined as described above. It
was found that 13(S)-9Z,11E-HODE was formed predomi-
nantly from both PC and CE (Fig. 4), again showing that
the LOX-catalyzed oxidation of plasma lipids proceeds enzy-
matically and speci¢cally. The ratio of S and R form of the
PC hydroperoxides decreased with time: S/R being 10.5, 6.98,
and 6.01 at 5, 200, and 300 min, respectively.
In order to compare the oxidation of plasma by LOX and
by free radicals, human plasma was oxidized with MeO-
AMVN. The results are included in Fig. 3. In contrast to
the oxidation induced by 15-LOX, hydroperoxides and hy-
droxides from both PC and CE increased with time and the
S/R ratio was close to one for both PC and CE hydroperox-
ides, showing that the oxidation gave random products.
4. Discussion
The results of the present study con¢rm the previous ob-
servation that CE in LDL particle is oxidized by rabbit retic-
ulocyte 15-LOX in a regio-, stereo- and enantio-speci¢c man-
ner, and show that PC in LDL is also oxidized speci¢cally and
that plasma lipids are oxidized similarly to give regio- and
enantio-speci¢c products. The selective formation of 13(S)-
9Z,11E-HODE from both PC and CE clearly demonstrates
that the oxidation of lipids in LDL and plasma by 15-LOX
proceeds by an enzymatic mechanism, not by free radical- or
K-tocopherol-mediated mechanism. It is interesting to note
that more CE hydroperoxides were formed than PC hydro-
peroxides from LDL, while the reverse order was observed in
the oxidation of plasma.
Another characteristic of 15-LOX-induced lipid peroxida-
tion is that the rate of oxidation decreased rapidly probably
due to its inactivation. As mentioned above, the fast oxidation
of plasma proceeded only about 5 min, after which the rate of
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Fig. 4. Geometrical and optical speci¢cities in the oxidation of plas-
ma by 15-lipoxygenase. Human plasma was incubated with rabbit
reticulocyte 15-lipoxygenase (49 nkat/ml) at room temperature in air
for 20 min. A: Phosphatidylcholine and cholesteryl ester hydroper-
oxides (PCOOH and CEOOH respectively) were collected and con-
verted into methyl hydroxylinoleate (HODE) and analyzed with an
HPLC. 1: 13-9Z,11E-HODE; 2: 13-9E,11E-HODE; 3: 9-10E,12Z-
HODE; 4: 9-10E,12E-HODE. B: 13-9Z,11E-HODE from PCOOH
and CEOOH were collected and analyzed with chiral phase HPCL
as described in Section 2. The standard products were obtained
from the oxidation of methyl linoleate with AMVN and analyzed
similarly.
Fig. 3. Oxidation of human plasma with (A) rabbit reticulocyte 15-lipoxygenase (50 nkat/ml) and (B) MeO-AMVN (2.0 mM) at 37‡C in air.
b : PC hydroperoxide; a : PC hydroxide; F : CE hydroperoxide; E : CE hydroxide.
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oxygen uptake became quite small and both PC and CE hy-
droperoxides decreased.
The results obtained in the present study are inconsistent
with those by Upston et al. [26,27] on the oxidation of LDL
by a recombinant human 15-LOX. They observed a stereo-
random formation of PC and CE hydroperoxides and con-
cluded that the oxidation proceeded by a tocopherol-mediated
random mechanism. The tocopherol content in the present
study was between 5^10 molecules per each LDL particle,
which is similar to those of Upston et al. [26,27]. The reason
for such a discrepancy is not clear but there may be two
possible explanations: (i) It may be possible that the native
rabbit and the recombinant human LOX behave di¡erently,
although an earlier study on LDL oxidation by the human
recombinant 15-LOX revealed a speci¢c pattern of oxidation
products [31]. (ii) The duration of incubation period in the
present study and that of Upston et al. [26,27] is quite di¡er-
ent. The oxidation for a short period employed in this and
previous studies gave speci¢c products selectively, while those
for long term incubation yielded more stereo-random oxida-
tion products [5,32]. It was also observed in the present study
that the S/R ratio of 13-9Z,11Z-HODE derived from either
PC or CE hydroperoxides decreased with increasing incuba-
tion time. It may be stated that the 15-LOX-induced lipid
peroxidation proceeds by a regio-, stereo- and enantio-speci¢c
mechanism but that the enzyme undergoes suicidal inactiva-
tion rapidly and then the speci¢c primary oxidation products
may initiate free radical-mediated secondary reactions or
undergo isomerization which lead to more or less unspeci¢c
oxidation products. It is not clear, however, whether and how
LOX may contribute to the secondary reactions of hydroper-
oxides.
In conclusion, the present study con¢rmed that the oxida-
tion of PC and CE in LDL and, more importantly, in plasma
by rabbit 15-LOX, proceeds enzymatically and gives speci¢c
products.
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